Research News and Research

RSS

Digital version of popular COVID-19 memorial launched

In fall 2020, thousands visited the COVID-19 public art installation "IN AMERICA How Could This Happen...," which took place just two miles east of the U.S. Capitol. People traveled from across the country to see personalized flags for those who had died. Today, the artist, Suzanne Brennan Firstenberg, with help from the George Washington University and University of Maryland, has launched a digital version in an effort to continue honoring those who have died.

1 Mar 2021

Toxicological assessment of hemp-containing foods

In order to avoid the occurrence of such effects, the Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV) recommended guidance values for maximum THC levels in various food groups in 2000.

1 Mar 2021

Cellular maps capture COVID-19 pathogenesis in detail

Researchers in the United States and Finland have used tissues from people who died from coronavirus disease 2019 (COVID-19) to generate detailed cellular maps of the pathogenetic processes that occur within affected organs during severe disease.

1 Mar 2021

Study could offer a new way to treat Type 1 and Type 2 diabetes

Blocking cell receptors for glucagon, the counter-hormone to insulin, cured mouse models of diabetes by converting glucagon-producing cells into insulin producers instead, a team led by UT Southwestern reports in a new study.

1 Mar 2021

New technique uncovers the tricks used by cancer cells to evade immunotherapies

By harnessing the immune system against cancer, immunotherapies have revolutionized the way some types of cancer are treated. But most patients--across cancer types--do not respond, and in most cases, scientists are at a loss as to why.

1 Mar 2021

High level of COVID-19 vaccine hesitancy found among Black Americans

Black Americans have a high level of vaccine hesitancy and mistrust of COVID-19 vaccines, including among Black health care workers, according to a new RAND Corporation survey.

1 Mar 2021

Scientists test the effect of natural product isolated from sea sponge on cancer cells

Scientists from Far Eastern Federal University together with Russian and German colleagues, continue studying antitumor compounds synthesized based on bioactive molecules isolated from a sea sponge.

1 Mar 2021

A region within GLI1 gene could potentially be targeted as cancer treatment

Scientists from the Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago found that a region within the DNA of the cancer-promoting GLI1 gene is directly responsible for regulating this gene's expression.

1 Mar 2021

NYU Oral Cancer Center receives $3.1 million grant to explore the interplay between nerves and cancer

NYU Oral Cancer Center has been awarded a five-year, $3.1 million grant (R01 CA231396) by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

1 Mar 2021

New, revolutionary theory for understanding brain and memory function

Research from the University of Kent has led to the development of the MeshCODE theory, a revolutionary new theory for understanding brain and memory function.

1 Mar 2021

Traumatic childhood and combat experiences associated with veterans' suicidal thoughts

The rate of suicide among post-9/11 military veterans has been rising for nearly a decade. While there are a number of factors associated with suicide, veterans have unique experiences that may contribute to them thinking about killing themselves.

1 Mar 2021

Study assesses causes of higher COVID-mortality among men

Researchers in the United States, Germany and Uganda have conducted a study showing that the factors responsible for a higher rate of coronavirus disease 2019 (COVID-19) mortality among males are specific to COVID-19 rather than related to men’s shorter life expectancy.

1 Mar 2021

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new antibodies against genetically altered proteins to target cancers.

1 Mar 2021